EssilorLuxottica

EL

FR0000121667

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris Other stock markets 09:30:12 2024-04-19 am EDT			5-day change	1st Jan Change
203.8 ^EUR	-0.44%		+0.49%	+12.22%

02:09pm	ESSILORLUXOTTICA : UBS gives a Neutral rating	ZD
12:50pm	ESSILORLUXOTTICA : UBS reiterates its recommendation on the stock	CF

ESSILORLUXOTTICA : Buy rating from Bernstein

August 15, 2022 at 07:17 am EDT

Luca Solca from Bernstein retains his positive opinion on the stock with a Buy rating. The target price is increased from EUR 192 to EUR 198.

Latest news about EssilorLuxottica

ESSILORLUXOTTICA : UBS gives a Neutral rating	08:09am	ZD
ESSILORLUXOTTICA : UBS reiterates its recommendation on the stock	06:50am	CF
ESSILORLUXOTTICA : Receives a Buy rating from Goldman Sachs	02:34am	ZD
ESSILORLUXOTTICA : JP Morgan reiterates its Buy rating	01:43am	ZD
EssilorLuxottica Q1 Revenue Rises, Outlook Affirmed	11:24pm	MT
ESSILORLUXOTTICA : Jefferies remains Neutral	Apr. 18	ZD
ESSILORLUXOTTICA : RBC sticks Neutral	Apr. 18	ZD
Meta releases early versions of its Llama 3 AI model	Apr. 18	RE
ESSILORLUXOTTICA : UBS sticks Neutral	Apr. 18	ZD
EssilorLuxottica Upbeat on Long-Term Outlook After Revenue Increase-- Update	Apr. 18	DJ
EssilorLuxottica Upbeat on Long-Term Outlook After Revenue Increase	Apr. 18	DJ
EssilorLuxottica: confirms sales growth target	Apr. 18	CF
Transcript : EssilorLuxottica Société anonyme, Q1 2024 Sales/ Trading Statement Call, Apr 18, 2024	Apr. 18
Ray-Ban maker EssilorLuxottica's revenues rose 5.5% in first quarter	Apr. 18	RE
Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix...	Apr. 18
Meta releases early versions of its Llama 3 AI model	Apr. 18	RE
EMEA Morning Briefing : Stocks Seen Broadly Higher as Focus Shifts to Earnings	Apr. 18	DJ
Inspecs hails "encouraging" recent trading after tepid start to 2024	Apr. 17	AN
France's CDC Increases Stake in EssilorLuxottica, Il Sole24 Ore Reports	Apr. 11	DJ
Deals of the day-Mergers and acquisitions	Apr. 09	RE
EssilorLuxottica buys Japan's Washin to expand its retail presence	Apr. 09	RE
EssilorLuxottica: acquisition of Washin Optical finalized	Apr. 09	CF
EssilorLuxottica Unit Finalizes Purchase of Japan-based Washin Optical	Apr. 09	MT
Oddo BHF Lifts EssilorLuxottica PT, Keeps Outperform Rating	Apr. 05	MT
ESSILORLUXOTTICA : RBC sticks Neutral	Apr. 05	ZD

EssilorLuxottica is a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. Formed in 2018, the company brings together the complementary expertise of two industry pioneers, one in advanced lens technology and the other in the craftsmanship of iconic eyewear, to set new industry standards for vision care and the consumer experience around it. Influential eyewear brands including Ray-Ban and Oakley, lens technology brands including Varilux® and Transitions®, and world-class retail brands including Sunglass Hut and LensCrafters are part of the EssilorLuxottica family.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-30 - Annual General Meeting

Related indices

CAC 40 , EURO STOXX 50 , STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ESSILORLUXOTTICA : Decent end to FY23; investors assessing if the mid-term profitability guidance is achievable

February 16, 2024 at 05:32 pm EST

More Strategies

Ratings for EssilorLuxottica

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

204.7 EUR

Average target price

205.9 EUR

Spread / Average Target

+0.58%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

	1st Jan change	Capi.
ESSILORLUXOTTICA	+12.22%	98.68B
ALCON INC.	+10.05%	39.04B
THE COOPER COMPANIES, INC.	-4.44%	17.97B
AUTEK CHINA INC.	-24.27%	2.12B
WARBY PARKER INC.	-15.74%	1.4B
PEGAVISION CORPORATION	+17.15%	1.12B
MINGYUE OPTICAL LENS CO.,LTD.	-37.86%	724M
MENICON CO., LTD.	-37.89%	731M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.	-7.76%	667M
VIZIONFOCUS INC.	+22.83%	491M

Glasses, Spectacles & Contact Lenses